Medarex Reviews

6 Reviews
3.8
6 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Medarex Chief Executive Officer Bristol-Myers Squibb Lamberto Andreotti
Lamberto Andreotti
1 Rating
  1.  

    Scientific Excellence

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Scientist I in Princeton, NJ
    Former Employee - Scientist I in Princeton, NJ

    I worked at Medarex full-time (more than 8 years)

    Pros

    The level of scientific expertise exceeded large biotech companies.

    Cons

    The management sold out before we went commercial.

    Advice to ManagementAdvice

    Be more committed to the employees.

    Doesn't Recommend
    Neutral Outlook
    No opinion of CEO

Medarex Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

0.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Scientist III Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Interview Details

    Interview process was straightforward and professional. Seminar went well, individual discussions were friendly and productive. Final salary was less than expected, as well as the stock options.

    Interview Questions
    • How to address a work related conflict with group member   Answer Question
    Accepted Offer

Medarex Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.medarex.com
Headquarters Princeton, NJ
Size 500 to 999 Employees
Founded Unknown
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year

Medarex is building the ultimate monoclonal antibody. Its UltiMAb technology utilizes transgenic mice whose antibody gene expression is suppressed to create fully human antibodies. Medarex has more than 40 developed or licensed antibodies for cancer, rheumatoid arthritis, and other autoimmune, inflammatory, and infectious diseases in clinical trials or pre-trial stages. The company has partnerships with numerous with pharma and biotech firms including Genmab, which has licensed antibody therapies for leukemia, psoriasis, and other conditions. Other development partners... More

Work at Medarex? Share Your Experiences

Medarex

 
Click to Rate
or